-
-
-
-
-
-
-
Precigen Inc. (PGEN) PT Raised to $11 at H.C. Wainwright
-
-
-
-
-
-
-
Medical experts recommend PAPZIMEOS as first-line RRP treatment, Precigen says
-
-
-
-
-
-
-
Increasing unusual call option volume: PGEN EXE MNSO DUST REAL XME CARR HE GDRX INDA SPGI
-
-
-
-
-
-
-
Precigen Inc. (PGEN) Misses Q1 EPS by 10c
-
-
-
-
-
-
-
Biotech outlook for 2025: Stifel
-
-
-
-
-
-
-
Precigen Inc. (PGEN) Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch
-
-
456,974 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

